The global hemophilia treatment market is on a strong growth trajectory, with projections indicating a rise from USD 12.1 billion in 2024 to a remarkable USD 18.7 billion by 2034. This growth, driven ...

Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

The Cybersecurity and Global Policy Program is co-led by Isak Nti Asare, assistant dean of undergraduate education and ...

The global opioid analgesics market is poised for substantial growth, projected to expand from USD 43.3 billion in 2023 to USD 72.0 billion by 2033, at a robust Compound Annual Growth Rate (CAGR) of 5 ...

Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...

Foreign Minister Melanie Joly said Canada needs more intelligence sharing and cooperation on defense from countries “we are ...

We explore key trends from HID Global's 2025 State of Security and Identity report, with additional insights from Memoori ...

As World Tuberculosis Day on March 24, 2025, approaches, global health authorities yet again find themselves at a crucial juncture in efforts to tackle the continuing global emergency of tuberculosis.

Sanofi's Sarclisa (isatuximab) has gained approval from Japan’s MHLW for use in conjunction with VRd to treat newly diagnosed ...

Food fuels our bodies and connects us to culture, livelihoods, and the environment. However, today’s food systems contribute ...